Mass Vaccination in a Pandemic – Benefits vs Risks
McMillan: I think the first thing that we have to clarify is that we have to explain you are someone who is in the vaccine development business, so to speak. What has that background been like? Bossche: Well, I have a background essentially in, as far as vaccines are concerned, in industry as well as … Read more